Get the Stockscreener App
0.301
7.31%
0.0205
After Hours:
.29
-0.011
-3.65%
Icecure Medical Ltd stock is traded at $0.301, with a volume of 1.05M.
It is up +7.31% in the last 24 hours and down -47.91% over the past month.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
See More
Previous Close:
$0.2805
Open:
$0.314
24h Volume:
1.05M
Relative Volume:
2.55
Market Cap:
$22.03M
Revenue:
$3.38M
Net Income/Loss:
$-15.06M
P/E Ratio:
-1.2836
EPS:
-0.2345
Net Cash Flow:
$-15.50M
1W Performance:
-50.57%
1M Performance:
-47.91%
6M Performance:
-70.34%
1Y Performance:
-74.40%
1-Day Range:
$0.28
$0.3216
1-Week Range:
$0.2771
$0.6341
52-Week Range:
$0.2771
$1.40
Icecure Medical Ltd Stock (ICCM) Company Profile
Compare ICCM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
0.301 | 20.53M | 3.38M | -15.06M | -15.50M | -0.2345 |
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Icecure Medical Ltd Stock (ICCM) Latest News
Fund Flows: Should I set a stop loss on IceCure Medical LtdShort Setup & Verified Trade Idea Suggestions - baoquankhu1.vn
IceCure Medical Ltd. (ICCM) Q2 Earnings Surpass Estimates - MSN
ICCM SEC FilingsIcecure Medical Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan
IceCure (NASDAQ: ICCM) offers 8M shares with 16M private warrants - Stock Titan
Epoch updates 45.8% IceCure Medical (ICCM) stake and board change - Stock Titan
IceCure Medical (ICCM) prices $4M share sale with concurrent warrants - Stock Titan
IceCure prices $4M direct offering, concurrent private placement - MSN
IceCure Medical (ICCM) Secures $4M Through Direct Offering - gurufocus.com
IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement - ChartMill
[Form 3] IceCure Medical Ltd. Initial Statement of Beneficial Ownership - Stock Titan
Huang Yang reports RSUs and options in IceCure Medical (NASDAQ: ICCM) - Stock Titan
IceCure Medical (NASDAQ: ICCM) director Chan Vincent Chun Hung files Form 3 - Stock Titan
IceCure Medical (ICCM) VP discloses shares, RSUs and option grants - Stock Titan
IceCure Medical (ICCM) COO discloses share, option and RSU stakes - Stock Titan
IceCure Medical (ICCM) VP details RSUs and stock option grants - Stock Titan
IceCure Medical (ICCM) CFO details shares, RSUs and options in Form 3 - Stock Titan
IceCure Medical (ICCM) director discloses shares and options in Form 3 - Stock Titan
IceCure Medical (ICCM) VP Naum Muchnik details insider share and option holdings - Stock Titan
IceCure Medical (ICCM) VP details share, option and RSU holdings - Stock Titan
IceCure Medical (ICCM) CEO details share, RSU and option stakes - Stock Titan
IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates - Bitget
IceCure Medical Posts Strong 5-Year Kidney Cancer Cryoablation Data From ICESECRET Trial - TipRanks
IceCure Medical Ltd Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study - marketscreener.com
IceCure Medical (ICCM) Reports Positive Outcomes in Kidney Cance - gurufocus.com
IceCure Medical (Nasdaq: ICCM) unveils 5-year kidney cancer data - Stock Titan
IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates (2026-03-25) - Seeking Alpha
IceCure names Meir Peleg as CFO - Medical Buyer
[EFFECT] IceCure Medical Ltd. SEC Filing - Stock Titan
IceCure Appoints Meir Peleg as Chief Financial Officer - citybiz
IceCure Medical Names New CFO and Plans Key Leadership Changes Amid ProSense® Growth - TipRanks
IceCure Medical (NASDAQ: ICCM) hires Meir Peleg as new CFO - Stock Titan
IceCure Appoints Meir Peleg as Chief Financial Officer (2026-03-24) - Seeking Alpha
[EFFECT] IceCure Medical Ltd.... | ICCM SEC FilingForm EFFECT - Stock Titan
Dip Buying: Is IceCure Medical Ltd subject to activist investor interest2026 Selloffs & Precise Buy Zone Identification - baoquankhu1.vn
Published on: 2026-03-22 01:37:56 - baoquankhu1.vn
Icecure Medical Ltd (ICCM) Q4 2025 Earnings Call Highlights: Record Sales and Strategic U.S. ... By GuruFocus - Investing.com Canada
Ideas Watch: What dividend growth rate does IceCure Medical Ltd offerM&A Rumor & Breakout Confirmation Trade Signals - baoquankhu1.vn
Icecure Medical Ltd (ICCM) Q4 2025 Earnings Call Highlights: Rec - GuruFocus
IceCure Medical (NASDAQ: ICCM) registers $100M shelf for shares and warrants - Stock Titan
IceCure Medical (NASDAQ: ICCM) registers 9.74M shares from outstanding warrants - Stock Titan
History Review: Is IceCure Medical Ltd stock a good dividend stock2026 Volume & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
IceCure Medical Ltd (NASDAQ:ICCM) Q4 2025 earnings call transcript - MSN
IceCure Medical Ltd (NASDAQ:ICCM) Q4 2025 Earnings Call Transcript - Insider Monkey
IceCure reports net loss of USD 15,057,000 in 2025 - Medical Buyer
Icecure Medical Rides FDA, ASBRS Wins to Growth - TipRanks
IceCure Medical Discloses Resignation of Director Li Haixiang - TipRanks
IceCure Medical (ICCM) director Li Haixiang steps down from board - Stock Titan
IceCure Medical (ICCM) Q4 2025 Earnings Transcript - AOL.com
IceCure Medical Ltd Announces Resignation of Li Haixiang as Member of the Board of Directors, Effective March 17, 2026 - marketscreener.com
IceCure Medical 2025 Financial Results Review | ProSense System UpdatesNews and Statistics - IndexBox
IceCure Medical (ICCM) Fourth Quarter 2025 Earnings Call Transcript - Bitget
Icecure Medical Ltd Stock (ICCM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):